Landmark pancreatic cancer drug shows potential against lung cancer too - Nature

Landmark pancreatic cancer drug shows potential against lung cancer too  NatureFDA approves landmark pancreatic cancer drug that's shown to improve survival  WUSA9Breakthrough Pancreatic Cancer Drug Shows Promise In Lung Cancer Trial  forbes.comA $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs  The New York TimesRevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer  biospace.com